1Li J P, Zheng C L, Han Z C, et al.Abnormal immunity and stem/ progenitor cells in acquired aplastic anemia[J].Crit Rev Oncol Hematol, 2010, 75(2): 79-93.
3Marsh J C, Ball S E, Cavenagh J, et al.Guidelines for the diagnosis and managementofaplasticanemia[J].BrJHaematol, 2009, 147(1): 43-70.
4Young N S, Bacigalupo A, Marsh J C, et al.Aplastic anemia: pathophysiology and treatment[J].Biol Blood Marrow Transplant, 2010, 16(1): S119-S125.
5Savage S A, Pulsipher M A, Romano A, et al.Aplastic Anemic & MDS Internation Founadation(AA & MDSIF): bone marrow failure disease scientific symposium 2012[J].Leuk Res, 2013, 37(7): 848-851.
6Yu H, Zhang J, Fu R, et al.Increased frequency of bone marrow T follicular helper cells in patients with immune-related pancytopenia[J].Clin DevImmunol, 2013, 45(2): 730450.
7Takamatsu H, Yagasaki H, Takahashi Y, et al.Aplastie anemia successfully treated with rituximab: the possible role of aplastie anemia- associated antibody as a marker for response[J].Eur J Hematol, 2011, 86(6): 541-545.
8Mufti G J, Bennett J M, Goasguen J, et al.Diagnosis and classification of myelodysplastie syndrome: International Working Group on Morphology of myelodysplastie syndrome(IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts[J]. Haematologica, 2008, 93(11): 1712-1717.
10Fend F, Bock O, Kremer M, et al.Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies[J]. VirchowsArch, 2005, 447(6): 909-919.
